Quantum Genomics Société Anonyme (QNNTF)
USD 0.1
(0.0%)
USD 0.1
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -3.17 Million EUR | 85.96% |
| 2022 | -24.93 Million EUR | -26.38% |
| 2021 | -19.73 Million USD | 0.6% |
| 2020 | -19.85 Million USD | -94.8% |
| 2019 | -10.19 Million USD | 25.65% |
| 2018 | -13.7 Million USD | -21.67% |
| 2017 | -11.26 Million USD | -103.77% |
| 2016 | -5.52 Million USD | -35.2% |
| 2015 | -4.08 Million USD | -53.13% |
| 2014 | -2.67 Million USD | -25.73% |
| 2013 | -2.12 Million USD | -91.02% |
| 2012 | -1.11 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -8.8 Million USD | 0.0% |
| 2023 FY | -3.49 Million USD | 85.96% |
| 2023 Q3 | -626.57 Thousand USD | 71.07% |
| 2023 Q4 | -654.31 Thousand USD | -4.43% |
| 2023 Q2 | -2.16 Million USD | -101.11% |
| 2023 Q1 | -1.07 Million USD | 87.5% |
| 2022 FY | -24.93 Million EUR | -26.38% |
| 2022 Q4 | -8.61 Million USD | -9.27% |
| 2022 Q3 | -7.88 Million USD | 37.08% |
| 2022 Q2 | -12.52 Million USD | 0.0% |
| 2021 Q2 | -7.32 Million USD | 0.0% |
| 2021 FY | -19.73 Million USD | 0.6% |
| 2020 FY | -19.85 Million USD | -94.8% |
| 2019 Q4 | -5.55 Million USD | 0.0% |
| 2019 FY | -10.19 Million USD | 25.65% |
| 2019 Q2 | -4.7 Million USD | 0.0% |
| 2018 Q4 | -6.6 Million USD | 0.0% |
| 2018 FY | -13.7 Million USD | -21.67% |
| 2018 Q2 | -7.24 Million USD | 0.0% |
| 2017 Q4 | -6.41 Million USD | 0.0% |
| 2017 FY | -11.26 Million USD | -103.77% |
| 2017 Q2 | -4.6 Million USD | 0.0% |
| 2016 Q2 | -3.05 Million USD | 0.0% |
| 2016 Q4 | -2.62 Million USD | 0.0% |
| 2016 FY | -5.52 Million USD | -35.2% |
| 2015 FY | -4.08 Million USD | -53.13% |
| 2014 FY | -2.67 Million USD | -25.73% |
| 2013 FY | -2.12 Million USD | -91.02% |
| 2012 FY | -1.11 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 95.77% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | 51.781% |
| SQZ Biotechnologies Company | -79.46 Million USD | 96.01% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 105.985% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 104.868% |
| Mesoblast Limited | -87.95 Million USD | 96.395% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -74.177% |
| Genus plc | 7.9 Million USD | 140.139% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | 70.887% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | 14.535% |
| Marizyme, Inc. | -65.34 Million USD | 95.148% |
| ContraFect Corporation | -65.15 Million USD | 95.133% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | 64.146% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | 35.102% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -83.562% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -9.631% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | 60.657% |
| MultiCell Technologies, Inc. | -380.07 USD | -834206.049% |
| Accustem Sciences Inc. | -3.74 Million USD | 15.361% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 93.866% |
| EV Biologics, Inc. | -1.26 Million USD | -150.246% |
| Q BioMed Inc. | -2.05 Million USD | -54.523% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | 15.056% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -401.409% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -33.184% |
| Biomind Labs Inc. | -1.21 Million USD | -161.13% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -10.54 Million USD | 69.938% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | 59.877% |
| Skye Bioscience, Inc. | -37.64 Million USD | 91.577% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -46.139% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -21073.524% |
| Arch Therapeutics, Inc. | -6.98 Million USD | 54.589% |
| IMV Inc. | -36.48 Million USD | 91.309% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 80.021% |
| Curative Biotechnology, Inc. | -5.81 Million USD | 45.491% |
| GB Sciences, Inc. | -1.36 Million USD | -132.871% |
| Alpha Cognition Inc. | -13.77 Million USD | 76.976% |
| HST Global, Inc. | -146.21 Thousand USD | -2068.762% |
| CSL Limited | 2.64 Billion USD | 100.12% |
| Halberd Corporation | -79.67 Thousand USD | -3879.802% |
| Enzolytics Inc. | -2.17 Million USD | -45.668% |
| Resverlogix Corp. | -3.61 Million USD | 12.162% |
| Affymax, Inc. | -14.42 Million USD | 78.016% |
| SYBLEU INC | -180.3 Thousand USD | -1658.667% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | 0.015% |
| argenx SE | -295.05 Million USD | 98.925% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 94.935% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 3335.66% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | 20.187% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -4.785% |
| AVAX Technologies, Inc. | -6.41 Million USD | 50.559% |
| Zenith Capital Corp. | -10.59 Million USD | 70.074% |
| Genscript Biotech Corporation | -95.47 Million USD | 96.679% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -13543.176% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | 23.517% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -5146.385% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 94.691% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -2.23% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.05 Million USD | -200.263% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -62.675% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | 16.969% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -58.143% |
| BioStem Technologies, Inc. | -8.48 Million USD | 62.62% |
| ONE Bio Corp. | 8.67 Million USD | 136.546% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -618.434% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -137.447% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -80.704% |
| Agentix Corp. | -1.37 Million USD | -130.747% |
| LadRx Corporation | 400.44 Thousand USD | 891.86% |
| Cell Source, Inc. | -5.32 Million USD | 40.409% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -663.203% |
| Regen BioPharma, Inc. | 1.02 Million USD | 409.812% |
| Regen BioPharma, Inc. | 1.02 Million USD | 409.812% |
| NovAccess Global Inc. | -4.76 Million USD | 33.512% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 145.793% |
| Itoco Inc. | -1.86 Million USD | -69.661% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | 28.623% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -89.991% |
| Kadimastem Ltd | -3.3 Million USD | 4.126% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -1059.811% |
| CytoDyn Inc. | -49.84 Million USD | 93.638% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -3912.181% |
| Mobile Lads Corp. | -2.26 Million USD | -40.103% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -1289.992% |
| Qrons Inc. | -789.34 Thousand USD | -301.718% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -236.787% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.08 Million USD | -51.888% |
| Rebus Holdings, Inc. | -1.02 Million USD | -210.877% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -96.619% |
| International Stem Cell Corporation | -131 Thousand USD | -2320.57% |
| Bioxytran, Inc. | -4.28 Million USD | 25.912% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -5742.694% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -25.322% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 93.404% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -49.997% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -306.07% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -0.093% |
| Neutra Corp. | -233.46 Thousand USD | -1258.211% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 84.373% |
| PureTech Health plc | -65.69 Million USD | 95.173% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 85.089% |
| IXICO plc | -1.17 Million USD | -169.181% |
| IntelGenx Technologies Corp. | -9.92 Million USD | 68.057% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 94.449% |
| CSL Limited | 2.64 Billion USD | 100.12% |
| Cellectis S.A. | -103.17 Million USD | 96.927% |